“…Carrageenan is not degraded nor absorbed in the gastrointestinal tract [110,111,112] and should not contain low Mw fractions, poligeenan or degraded carrageenan, since it exhibits toxicological properties at high doses [110] and can induce gastrointestinal irritation and cancer in animal models [112] or can lead to cell death and inflammatory responses on human colonic epithelial cells [113,114], bacterial dysbiosis and shifted community composition [115] and decreased anti-inflammatory bacteria [116]. Further studies of its impact on digestive proteolysis, the colon microbiome and inflammation [117,118,119] and the effects on predisposed populations [119,120] are required. Carrageenans are also used for the pharmaceutical sector [106,107], based on anti-inflammatory [121], antiviral [6,122,123,124,125,126], anticoagulant [17,127], immunomodulatory [128], antitumoral [129], antioxidant [17,129,130], anti-angiogenic [97] and neuroprotective [129] activities.…”